Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 142; no. 19; pp. 1878 - 1880
Main Authors Omland, Torbjørn, Prebensen, Christian, Røysland, Ragnhild, Søvik, Signe, Sørensen, Vibecke, Røsjø, Helge, Svensson, My, Berdal, Jan Erik, Myhre, Peder L
Format Journal Article
LanguageEnglish
Published United States by the American College of Cardiology Foundation and the American Heart Association, Inc 10.11.2020
Lippincott Williams & Wilkins
Subjects
Adult
Aged
Aged, 80 and over
Betacoronavirus - isolation & purification
Biomarkers - analysis
C-Reactive Protein - analysis
Cardiovascular Diseases - complications
Cardiovascular Diseases - pathology
Coronavirus Infections - complications
Coronavirus Infections - pathology
Coronavirus Infections - virology
Correspondence
COVID-19
Female
Fibrin Fibrinogen Degradation Products - analysis
Hospitalization
Humans
Male
Middle Aged
Multivariate Analysis
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - pathology
Pneumonia, Viral - virology
Prognosis
Prospective Studies
SARS-CoV-2
Troponin T - analysis
COVID-19
mortality
cardiovascular diseases
prognosis
biomarkers
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.120.050089